Harvard Bioscience's Upcoming Engagement at Sidoti Micro Cap
In an exciting announcement from Harvard Bioscience, Inc. (Nasdaq: HBIO), the company is preparing for an engagement at the upcoming Sidoti Micro Cap Virtual Conference. Jim Green, the Chairman and Chief Executive Officer, alongside Jennifer Cote, the Chief Financial Officer, will represent the company. This highly anticipated presentation is scheduled to take place on January 22, 2025, starting at 10:00 am ET.
Engagement Details and Access
The presentation will be accessible via a live webcast, which can be found within the investor relations section of the Harvard Bioscience website. Following the presentation, a replay will be made available for those who miss the live event. This approach allows for greater engagement and understanding among stakeholders and potential investors.
Meeting Opportunities
For individuals interested in a more personalized interaction, there are options for one-on-one meetings. Attendees are encouraged to contact the conference organizers directly to schedule these meetings, creating avenues for more tailored discussions.
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. stands at the forefront of technological innovation, providing a wide array of products and services designed to facilitate crucial advancements in life sciences. The company’s portfolio is integral to research, pharmaceutical discovery, bio-production, and preclinical testing processes that are foundational in the path to pharmaceutical and therapeutic development.
Global Reach and Customer Base
Harvard Bioscience caters to a diverse clientele that includes esteemed academic institutions, government labs, and leading organizations in the pharmaceutical and biotechnology sectors. Its operations span across North America, Europe, and China, ensuring a robust presence in the global market.
Commitment to Innovation
The company's commitment to innovation is reflected in its strategic approach to selling, utilizing both direct and distribution channels to reach its customers effectively. This dedication not only supports Harvard Bioscience's growth but also helps advance scientific research and development on a global scale.
Future Developments
As Harvard Bioscience continues its journey in the life sciences sector, the company remains focused on enhancing its product offerings and expanding its global footprint, ensuring it remains a pivotal player in the industry.
Frequently Asked Questions
What will Harvard Bioscience present at the conference?
Harvard Bioscience will highlight its advancements and innovations in life science technologies at the Sidoti Micro Cap Virtual Conference.
When is the Sidoti Micro Cap Conference?
The Sidoti Micro Cap Conference will take place on January 22, 2025, with Harvard Bioscience's presentation scheduled for 10:00 am ET.
Where can I watch the presentation?
The presentation will be available via live webcast on the investor relations section of the Harvard Bioscience website.
How can I schedule a meeting with Harvard Bioscience?
Interested parties can reach out to the conference organizers directly to arrange one-on-one meetings with company representatives.
Who should I contact for more information?
For further inquiries, you can reach out to Jennifer Cote, Chief Financial Officer of Harvard Bioscience, at (508) 893-3120.
